Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.05
  • 52 Week Low: 0.70
  • Currency: UK Pounds
  • Shares Issued: 427.35m
  • Volume: 14,825
  • Market Cap: £3.21m
  • Beta: 0.11

Regulatory News

Holding(s) in Company 02-May-2024 10:47 RNS
Total Voting Rights 02-May-2024 07:00 RNS
Change of Name 25-Apr-2024 15:46 RNS
Holding(s) in Company 22-Apr-2024 10:11 RNS
Holding(s) in Company 11-Apr-2024 15:04 RNS
Holding(s) in Company 09-Apr-2024 07:00 RNS
Holding(s) in Company 08-Apr-2024 16:03 RNS
Director/PDMR Shareholding 05-Apr-2024 15:39 RNS
Holding(s) in Company 05-Apr-2024 14:40 RNS
Result of General Meeting 04-Apr-2024 13:59 RNS
Result of Retail Offer 04-Apr-2024 07:00 RNS
Retail Offer 19-Mar-2024 17:03 RNS
Acquisition, Fundraising and Change of Name 19-Mar-2024 17:00 RNS
Notice of Dispute lodged with Stalicla SA 09-Feb-2024 11:01 RNS
Holding(s) in Company 29-Dec-2023 11:29 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.05
52 Week Low 0.70
Volume 14,825
Shares Issued 427.35m
Market Cap £3.21m
Beta 0.11

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
93.43% below the market average93.43% below the market average93.43% below the market average93.43% below the market average93.43% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:10 604 @ 0.75p
15:39 1,764 @ 0.79p
11:59 12,457 @ 0.70p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page